Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...
The FDA's fast track designation acknowledges the combination's promising early efficacy and safety profile in treating MSS mCRC. Early data from a phase 1b/2 study showed deep, durable responses with ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to muzastotug when used in combination with Keytruda (pembrolizumab) to treat adult patients with microsatellite stable ...
Nine-year-old Aden Kneller became a New York Knicks fan while bedridden in the hospital. On Wednesday, Dec. 3, the cancer ...
Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...
Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy ...
| READ NEXT: Holy ground: A reflection for the healers during challenging times Doctors told Carr the donor was Stacey Holden ...
The MarketWatch News Department was not involved in the creation of this content.-- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment ...
Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...
Nick LaLuna of Kankakee is celebrating the holidays cancer-free, nearly three years after being told his liver cancer was ...
Maureen Kamischke shares with PEOPLE her daughter’s struggle with hepatitis B — and why it’s so important not to delay vaccination. Now 28, her daughter still has liver damage.
A breakthrough therapy is driving aggressive leukaemia into remission. Here’s what the headlines don’t tell you about life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback